CLA-2-29:OT:RR:NC:N2:238
Ms. Amy Liang
Pharmaports LLC
1 E. Uwchlan Avenue, Suite 116
Exton, PA 19341
RE: The tariff classification of Sacubitril Sodium (CAS 149690-05-1) in bulk form, from Taiwan
Dear Ms. Liang:
In your letter dated May 25, 2016, you requested a tariff classification ruling.
The subject product, Sacubitril Sodium, is a neprilysin inhibitor that is indicated for use as an antihypertensive drug.
The applicable subheading for the Sacubitril Sodium in bulk form will be 2924.29.6250, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Carboxyamide-function compounds; amide-function compounds of carbonic acid: Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: Other: Aromatic: Other: Drugs: Other: Other ” The rate of duty will be 6.5 percent ad valorem. Currently, Sacubitril Sodium is not listed in the Pharmaceutical Appendix to the Tariff Schedule.
Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected].
Sincerely,
Deborah C. Marinucci
Acting Director
National Commodity Specialist Division